Document:

Exhibit 10.22

 

NOTICE AND TERMINATION AGREEMENT

 

This Notice and Termination Agreement (this “Agreement”) is being entered into on October 25, 2011, by and among J.W. Child Associates, L.P., a Delaware limited partnership (the “Consultant”), Mattress Intermediate Holdings, Inc., a Delaware corporation (“Intermediate Holdings”), Mattress Holding Corp., a Delaware corporation (the “Company”) and Mattress Firm, Inc., a Delaware corporation (“Mattress Firm” and, together with Intermediate Holdings and the Company, the “Clients”).

 

WHEREAS, reference is made to that certain to that certain Amended Management Agreement, dated as of March 20, 2009, by and among the Clients and the Consultant (the “Management Agreement”);

 

WHEREAS, Mattress Firm Holding Corp., a Delaware corporation formerly known as Mattress Interco, Inc. and the parent of Intermediate Holdings (“Mattress Firm Holding”), filed for the initial public offering of shares of its common stock (the “Initial Public Offering”) pursuant to a registration statement that was initially filed with the Securities and Exchange Commission on June 10, 2011; and

 

WHEREAS, in connection with the completion of the Initial Public Offering, Mattress Firm Holding and the Clients have requested that the Consultant agree to an early termination of the Management Agreement, and the Consultant has agreed to grant such early termination subject to the terms and conditions provided for herein.

 

NOW THEREFORE, in consideration of the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

1.                                       Definitions.  Capitalized terms used but not defined in this Agreement shall have the definitions set forth in the Management Agreement.

 

2.                                       Notice.  The Consultant hereby delivers notice, pursuant to clause (b) of Section 2 of the Management Agreement, that effective upon the closing of the Initial Public Offering, the Management Agreement shall terminate in accordance with its terms.

 

3.                                       Payments Upon Termination.

 

(a)                                  In light of the termination of the Management Agreement effected by Section 2 thereof,  Mattress Firm Holding shall pay (or cause the Clients to pay) upon the closing of the Initial Public Offering, any and all accrued and unpaid obligations of the Clients owed to the Consultant under Section 5.1 of the Management Agreement, which amount is derived as the amount shown in the column titled “Outstanding Fees” in Exhibit I, as of the most recent “Pmt Due” date in Exhibit I preceding the date of the

 

 

closing of the Initial Public Offering (“Most Recent Date”), plus a per diem amount that will be calculated as the amount shown in the “Pier Diem Fees” column in Exhibit I as of the Most Recent Date multiplied by the number of days from the Most Recent Date to and including the date of the closing of the Initial Public Offering; and

 

(b)                                 As an inducement for the Consultant to deliver notice under Section 2 hereof and thereby effect an early termination of the Management Agreement, Mattress Firm Holding shall also pay (or cause the Clients to pay) the Consultant the sum of $360,000 upon the closing of the Initial Public Offering.

 

4.                                       Expiration of this Agreement. In the event that the Initial Public Offering is not consummated on or prior to March 31, 2012, (i) the notice set forth in Section 2 of this Agreement shall be deemed to have been revoked and the termination effected thereby shall each be deemed void ab initio and of no effect and (ii) the Management Agreement shall continue in accordance with its terms.

 

5.                                       Indemnification Priority. The Clients hereby confirm that the Company shall be fully and primarily responsible for the payment of all Obligations to each Indemnitee, howsoever such right to indemnification or advancement from the Company arises, without regard to (a) any right of recovery the Indemnitee may have from a third party or (b) any right to insurance coverage that the Indemnitee may have under any insurance policy.  Under no circumstance shall any Client be entitled to any right of subrogation, reimbursement, exoneration, indemnification or contribution from any such third party or insurance carrier pursuant to any right of indemnification that the Indemnitee may have under any contract, insurance policy or otherwise, and no Client shall have any right to participate in any claim or remedy of the Indemnitee in respect thereof.  No right of indemnification, reimbursement, advancement of expenses or insurance coverage or any other right of recovery of the Indemnitee may have from any third party or insurance carrier shall reduce or otherwise alter the rights of the Indemnitee or the obligations of the Clients under Section 6 of the Management Agreement.  Each Client hereby unconditionally and irrevocably waives, relinquishes and releases, and covenants and agrees not to exercise any rights that it may now have or hereafter acquire against any Indemnitee that arises from or relates to the existence, payment, performance or enforcement of such Client’s obligations under the Management Agreement or under any other indemnification agreement (whether pursuant to contract, by-laws or charter), including, without limitation, any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy of the Indemnitee against any third party or insurance carrier, whether or not such claim, remedy or right arises in equity or under contract, statute or common law, including, without limitation, the right to take or receive, directly or indirectly, in cash or other property or by set-off or in any other manner, payment or security on account of such claim, remedy or right.

 

 

6.                                       Governing Law.  This Agreement shall be governed by and construed in accordance with the law of The State of New York without giving effect to any choice or conflict of law provision or rule that would cause the application of the aw of any other jurisdiction.

 

7.                                       Amendments and Waivers.  No amendment or waiver of any term, provision or condition of this Agreement shall be effective as against any party, unless in writing and executed such party.

 

8.                                       Entire Agreement.  This Agreement contains the entire understanding of the parties with respect to the subject matter hereof and supersedes any prior communication or agreement with respect thereto.

 

9.                                       Counterparts.  This Agreement may be executed in any number of counterparts and by each of the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which together shall constitute one and the same agreement.

 

[Remainder of Page Intentionally Left Blank]

 

 

IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf as of the date first above written by its officer or representative thereunto duly authorized.

 

 

	
The   Consultant:
    	
 
    	
J.W.   Childs Associates, L.P.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:   
    	
/s/   David Fiorentino
    
	
 
    	
 
    	
 
    	
Name:   David Fiorentino
    
	
 
    	
 
    	
 
    	
Title:   Partner
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
The   Clients:
    	
 
    	
Mattress   Intermediate Holdings, Inc.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:   
    	
/s/   Jim R. Black
    
	
 
    	
 
    	
 
    	
Name:
    	
Jim   R. Black
    
	
 
    	
 
    	
 
    	
Title:
    	
Chief   Financial Officer
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Mattress   Holding Corp.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Jim R. Black
    
	
 
    	
 
    	
 
    	
Name:
    	
Jim   R. Black
    
	
 
    	
 
    	
 
    	
Title:   
    	
Chief   Financial Officer
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Mattress   Firm, Inc.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:   
    	
/s/   Jim R. Black
    
	
 
    	
 
    	
 
    	
Name:
    	
Jim   R. Black
    
	
 
    	
 
    	
 
    	
Title:   
    	
Chief   Financial Officer
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
Mattress   Firm Holding:
    	
 
    	
Mattress   Firm Holding Corp.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:   
    	
/s/   Jim R. Black
    
	
 
    	
 
    	
 
    	
Name:
    	
Jim   R. Black
    
	
 
    	
 
    	
 
    	
Title:
    	
Chief   Financial Officer
    

 

Signature Page to Notice and Termination Agreement

 

 

Exhibit I

 

	
 
    	
 
    	
 
    	
 
    	
Interest
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
Pmt
    	
 
    	
Monthly
    	
 
    	
16.0%
    	
 
    	
 
    	
 
    	
Outstanding
    	
 
    	
Per
    	
 
    
	
Due
    	
 
    	
Fee
    	
 
    	
Accrued
    	
 
    	
PIK
    	
 
    	
Fees
    	
 
    	
Diem Fees
    	
 
    
	
4/1/09
    	
 
    	
$
    	
30,000.00
    	
 
    	
 
    	
 
    	
 
    	
 
    	
$
    	
30,000.00
    	
 
    	
 
    	
 
    
	
5/1/09
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
394.52
    	
 
    	
$
    	
394.52
    	
 
    	
$
    	
60,394.52
    	
 
    	
 
    	
 
    
	
6/1/09
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
820.70
    	
 
    	
 
    	
 
    	
$
    	
90,394.52
    	
 
    	
$
    	
1,039.62
    	
 
    
	
7/1/09
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
1,188.75
    	
 
    	
 
    	
 
    	
$
    	
120,394.52
    	
 
    	
$
    	
1,020.52
    	
 
    
	
8/1/09
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
1,636.05
    	
 
    	
$
    	
3,645.50
    	
 
    	
$
    	
154,040.02
    	
 
    	
$
    	
1,035.27
    	
 
    
	
9/1/09
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
2,093.26
    	
 
    	
 
    	
 
    	
$
    	
184,040.02
    	
 
    	
$
    	
1,080.68
    	
 
    
	
10/1/09
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
2,420.25
    	
 
    	
 
    	
 
    	
$
    	
214,040.02
    	
 
    	
$
    	
1,061.57
    	
 
    
	
11/1/09
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
2,908.60
    	
 
    	
$
    	
7,422.11
    	
 
    	
$
    	
251,462.13
    	
 
    	
$
    	
1,110.23
    	
 
    
	
12/1/09
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
3,306.90
    	
 
    	
 
    	
 
    	
$
    	
281,462.13
    	
 
    	
$
    	
1,091.12
    	
 
    
	
1/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
3,824.80
    	
 
    	
 
    	
 
    	
$
    	
311,462.13
    	
 
    	
$
    	
1,104.27
    	
 
    
	
2/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
4,232.47
    	
 
    	
$
    	
11,364.17
    	
 
    	
$
    	
352,826.30
    	
 
    	
$
    	
1,226.09
    	
 
    
	
3/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
4,330.58
    	
 
    	
 
    	
 
    	
$
    	
382,826.30
    	
 
    	
$
    	
1,135.56
    	
 
    
	
4/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
5,202.24
    	
 
    	
 
    	
 
    	
$
    	
412,826.30
    	
 
    	
$
    	
1,180.96
    	
 
    
	
5/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
5,428.95
    	
 
    	
$
    	
14,961.77
    	
 
    	
$
    	
457,788.07
    	
 
    	
$
    	
1,168.42
    	
 
    
	
6/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
6,220.90
    	
 
    	
 
    	
 
    	
$
    	
487,788.07
    	
 
    	
$
    	
1,213.82
    	
 
    
	
7/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
6,414.75
    	
 
    	
 
    	
 
    	
$
    	
517,788.07
    	
 
    	
$
    	
1,194.72
    	
 
    
	
8/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
7,036.24
    	
 
    	
$
    	
19,671.89
    	
 
    	
$
    	
567,459.96
    	
 
    	
$
    	
1,216.49
    	
 
    
	
9/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
7,711.24
    	
 
    	
 
    	
 
    	
$
    	
597,459.96
    	
 
    	
$
    	
1,261.90
    	
 
    
	
10/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
7,857.01
    	
 
    	
 
    	
 
    	
$
    	
627,459.96
    	
 
    	
$
    	
1,242.79
    	
 
    
	
11/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
8,526.58
    	
 
    	
$
    	
24,094.82
    	
 
    	
$
    	
681,554.78
    	
 
    	
$
    	
1,298.76
    	
 
    
	
12/1/10
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
8,962.91
    	
 
    	
 
    	
 
    	
$
    	
711,554.78
    	
 
    	
$
    	
1,279.66
    	
 
    
	
1/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
9,669.35
    	
 
    	
 
    	
 
    	
$
    	
741,554.78
    	
 
    	
$
    	
1,292.81
    	
 
    
	
2/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
10,077.02
    	
 
    	
$
    	
28,709.28
    	
 
    	
$
    	
800,264.06
    	
 
    	
$
    	
1,422.23
    	
 
    
	
3/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
9,822.42
    	
 
    	
 
    	
 
    	
$
    	
830,264.06
    	
 
    	
$
    	
1,331.69
    	
 
    
	
4/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
11,282.49
    	
 
    	
 
    	
 
    	
$
    	
860,264.06
    	
 
    	
$
    	
1,377.10
    	
 
    
	
5/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
11,313.06
    	
 
    	
$
    	
32,417.97
    	
 
    	
$
    	
922,682.04
    	
 
    	
$
    	
1,372.21
    	
 
    
	
6/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
12,538.36
    	
 
    	
 
    	
 
    	
$
    	
952,682.04
    	
 
    	
$
    	
1,417.61
    	
 
    
	
7/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
12,528.42
    	
 
    	
 
    	
 
    	
$
    	
982,682.04
    	
 
    	
$
    	
1,398.51
    	
 
    
	
8/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
13,353.71
    	
 
    	
$
    	
38,420.49
    	
 
    	
$
    	
1,051,102.53
    	
 
    	
$
    	
1,428.50
    	
 
    
	
9/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
14,283.48
    	
 
    	
 
    	
 
    	
$
    	
1,081,102.53
    	
 
    	
$
    	
1,473.91
    	
 
    
	
10/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
14,217.24
    	
 
    	
 
    	
 
    	
$
    	
1,111,102.53
    	
 
    	
$
    	
1,454.80
    	
 
    
	
11/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
15,098.82
    	
 
    	
$
    	
43,599.53
    	
 
    	
$
    	
1,184,702.06
    	
 
    	
$
    	
1,519.32
    	
 
    
	
12/1/11
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
15,579.64
    	
 
    	
 
    	
 
    	
$
    	
1,214,702.06
    	
 
    	
$
    	
1,500.21
    	
 
    
	
1/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
16,506.64
    	
 
    	
 
    	
 
    	
$
    	
1,244,702.06
    	
 
    	
$
    	
1,513.36
    	
 
    
	
2/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
16,914.31
    	
 
    	
$
    	
49,000.59
    	
 
    	
$
    	
1,323,702.65
    	
 
    	
$
    	
1,614.74
    	
 
    
	
3/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
16,827.34
    	
 
    	
 
    	
 
    	
$
    	
1,353,702.65
    	
 
    	
$
    	
1,561.15
    	
 
    
	
4/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
18,395.52
    	
 
    	
 
    	
 
    	
$
    	
1,383,702.65
    	
 
    	
$
    	
1,606.55
    	
 
    
	
5/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
18,196.64
    	
 
    	
$
    	
53,419.50
    	
 
    	
$
    	
1,467,122.15
    	
 
    	
$
    	
1,610.86
    	
 
    
	
6/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
19,936.78
    	
 
    	
 
    	
 
    	
$
    	
1,497,122.15
    	
 
    	
$
    	
1,656.27
    	
 
    
	
7/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
19,688.18
    	
 
    	
 
    	
 
    	
$
    	
1,527,122.15
    	
 
    	
$
    	
1,637.17
    	
 
    
	
8/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
20,752.13
    	
 
    	
$
    	
60,377.09
    	
 
    	
$
    	
1,617,499.24
    	
 
    	
$
    	
1,676.78
    	
 
    
	
9/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
21,980.26
    	
 
    	
 
    	
 
    	
$
    	
1,647,499.24
    	
 
    	
$
    	
1,722.19
    	
 
    
	
10/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
21,665.74
    	
 
    	
 
    	
 
    	
$
    	
1,677,499.24
    	
 
    	
$
    	
1,703.08
    	
 
    
	
11/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
22,795.61
    	
 
    	
$
    	
66,441.61
    	
 
    	
$
    	
1,773,940.85
    	
 
    	
$
    	
1,777.62
    	
 
    
	
12/1/12
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
23,328.54
    	
 
    	
 
    	
 
    	
$
    	
1,803,940.85
    	
 
    	
$
    	
1,758.51
    	
 
    
	
1/1/13
    	
 
    	
$
    	
30,000.00
    	
 
    	
$
    	
24,513.83
    	
 
    	
 
    	
 
    	
$
    	
1,833,940.85
    	
 
    	
$
    	
1,790.22
    	
 
    
	
1/18/13
    	
 
    	
$
    	
16,767.12
    	
 
    	
$
    	
13,666.63
    	
 
    	
$
    	
61,508.99
    	
 
    	
$
    	
1,912,216.97
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
$
    	
1,396,767.12
    	
 
    	
$
    	
515,449.84
    	
 
    	
$
    	
515,449.84
    	
 
    	
$
    	
1,912,216.97Exhibit 10.23

 

Execution Version

 

November 4, 2011

 

Mattress Holding Corp.

5815 Gulf Freeway

Houston, TX 77023

Attn: Jim R. Black

 

Re: Amendment to Equity Support Letter

 

Reference is made to that certain Equity Support Letter (the “Equity Support Letter”), dated as of March 20, 2009, by and among J.W. Childs Equity Partners III, L.P. (the “Investor”), Mattress Holdings, LLC (“Mattress Holdings”), Mattress Firm Holding Corp. (such entity, formerly known as Mattress Interco, Inc., the “Company”), Mattress Intermediate Holdings, Inc. and TCW/Crescent Mezzanine Partners IV, L.P. (“TCW”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Equity Support Letter.

 

The undersigned, being all the parties necessary to effect an amendment of the Equity Support Letter in accordance with Section 7 thereof, hereby amend the Equity Support Letter as follows:

 

1. Section 3 of the Equity Support Letter is amended and restated in its entirety as follows:

 

“3.           Termination. This letter and the respective rights and obligations of the Investor and the other parties under this letter shall terminate automatically and immediately upon the earliest to occur of (a) such time as the aggregate amount of equity investments made in the Company under this letter equals or exceeds the Equity Cure Limit (including for this purpose indirect equity investments in the Company that are made directly in Mattress Holdings in the manner contemplated by Section 1(a) , which equity investments, for the avoidance of doubt, shall not again count toward the Equity Cure Limit when the proceeds thereof are contributed to the Company as contemplated by Section 1(a)), (b) June 5, 2012, (c) the conversion or payment of the entire amount outstanding under the Notes, including all accrued and unpaid amounts thereon, in accordance with the terms of the Notes (as defined in Section 12 hereof) and (d) the acceleration of any amounts due and payable due to the occurrence and continuance of either (i) an Event of Default pursuant to Section 8.01 of the Credit Agreement or (ii) an event of default pursuant to Section 8.01 of the Amended and Restated Loan Agreement dated as of the date hereof (the “Mezzanine Loan Agreement”), among Intermediate Holdings, the lenders from time to time party thereto and TCW, as Administrative Agent for such lenders; provided, however, the foregoing clause (d) will not apply if (A) the Investor or any Mattress Firm Company is in breach of its funding obligations under Section 1(a) of this letter (including for this purposes, in the case of Intermediate Holdings, its obligation to cause Holdings to exercise the Cure Right by making a capital contribution to the Borrower and notify the administrative agent under the Credit Agreement of such exercise in the manner contemplated by Section 1(a)) at the time of such acceleration or (B) the Event of Default or event of default, as the case may be, giving rise to such acceleration occurred when Holdings was not restricted under the Credit Agreement from exercising the Cure Right and was of the type that, subject to the Equity Cure Limit and the other

 

 

terms and conditions of this letter, could have been avoided by the exercise of the Cure Right using the proceeds of an equity investment under this letter; provided, further, however, that any such Event of Default or event of default resulting solely from actions undertaken by the Investor or any of its managers, members, partners, officers, directors, employees, Affiliates or affiliated funds with the intended purpose of causing the Borrower to intentionally breach any of its covenants under the Credit Agreement as part of a plan by the Investor to cause the termination of its obligations hereunder will not be considered an Event of Default or event of default, as the case may be, for purposes of the foregoing clause (d).”

 

1. A new Section 12 shall be added immediately after Section 11 of the Equity Support Letter as follows:

 

“              12.           Notes.    Reference is further made to the 12% payment-in-kind investor notes maturing at various times from October 24, 2012 through March 19, 2015 issued by the Company to TCW, TCW/Crescent Mezzanine Partners IVB, L.P., MAC Capital, Ltd., Life Insurance Company of North America, Connecticut General Life Insurance Company, Partners Group Mezzanine Finance II, L.P. and HSBC Partners Group Global Private Equity (collectively, the “Notes”).”

 

[The remainder of this page is intentionally left blank]

 

 

IN WITNESS WHEREOF, the parties hereto have executed this amendment to the Equity Support Letter as of the date first above written.

 

 

	
THE   INVESTOR:
    	
J.W.   CHILDS EQUITY PARTNERS III, L.P.
    
	
 
    	
 
    
	
 
    	
By:   J.W. Childs Advisors III. L.P., its General Partner
    
	
 
    	
By:   J.W. Childs Associates, L.P., its General Partner
    
	
 
    	
By:   J.W. Childs Associates, Inc., its General Partner
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:   
    	
/s/   David Fiorentino
    
	
 
    	
 
    	
Name:   David Fiorentino
    
	
 
    	
 
    	
Title:   Vice President
    
	
 
    	
 
    
	
 
    	
 
    
	
THE   COMPANY:
    	
MATTRESS   FIRM HOLDING CORP.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:   
    	
/s/   Jim R. Black
    
	
 
    	
 
    	
Name:   Jim R. Black
    
	
 
    	
 
    	
Title:   Chief Financial Officer
    
	
 
    	
 
    
	
 
    	
 
    
	
TCW:
    	
TCW/CRESCENT   MEZZANINE PARTNERS IV, L.P.,
    
	
 
    	
as   Administrative Agent for the lenders under the Mezzanine Loan Agreement
    
	
 
    	
 
    
	
 
    	
By:   
    	
TCW/Crescent   Mezzanine Management IV, L.L.C.,
    
	
 
    	
 
    	
its   Investment Manager.
    
	
 
    	
By:   
    	
Crescent   Capital Group LP, its Sub-Advisor
    
	
 
    	
By:   
    	
Crescent   Capital GP LLC, its General Partner
    
	
 
    	
 
    
	
 
    	
  By:
    	
/s/   Daniel Honeker
    
	
 
    	
 
    	
Name:   Daniel Honeker
    
	
 
    	
 
    	
Title:   Managing Director
    
				

 

Signature Page to Equity Support Letter Amendment

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}]]